Skip to content
Disclosery

13F-HR/A filed by Caligan Partners LP

Caligan Partners LP filed this 13F-HR/A for the quarter ended 2022-12-31, filed 2023-05-15, with 11 holding rows worth $120,160,498.

Accession
0001814554-23-000005
Filer
CIK 1727492
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, amendment of type restatement, 11 entries on the cover page, a total value of $120,160,498 stated on the cover page (in dollars after the unit check, H1), rows summing to $120,160,498 with VALUE read as dollars as filed, 13F file number 028-23096. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LIQUIDIA CORPORATION COM NEW53635D202Stock9,243,627$58,881,904dollars as filed
ANIKA THERAPEUTICS INC035255108COM591,675$17,513,580dollars as filed
EVOLUS INC30052C107COM1,740,700$13,072,657dollars as filed
ADMA BIOLOGICS INC000899104COM2,676,093$10,383,241dollars as filed
STANDARD BIOTOOLS INC34385P108COM8,576,799$10,034,855dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS183,064$4,783,462dollars as filed
SOCIETAL CDMO INC75629F109COM1,603,214$2,388,789dollars as filed
EYEPOINT INC COM NEW30233G209Stock435,298$1,523,543dollars as filed
ALIMERA SCIENCES INC016259202COM478,777$1,297,486dollars as filed
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock1,000$159,310dollars as filed
AGIOS PHARMACEUTICALS INC00847X104COM4,333$121,671dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001727492-23-000005 superseded2023-02-15acceptance time not in the bulk data set
13F-HR/A 0001814554-23-000005this filing2023-05-15acceptance time not in the bulk data set